According to the convening notice published at the Bucharest Stock Exchange, the amount is to be used to finance ”The Future Together” Business Plan and to co-finance the investment objective “Production, packaging and storage capacity of sterile products, solutions and topicals” which is the subject of the Financing Agreement no. 538 of May 17, 2023 of the Ministry of Finance.
Shareholders are also expected to approve the negotiation and signing of any other documents in connection with the financing contract including, without limitation, any withdrawal requests and any other additional or supplementary documents or related documents in connection with the financing documents.
Antibiotice Iasi ended the first half of 2023 with a turnover of RON315.9 million, up 27% on the year, and a net profit of RON62 million, up 82.8% on the year.
The company, with a market value of RON635.1 million, is 53%-owned by the Health Ministry and 29.4% by Infinity Capital Investments. ATB shares have gained 67.1% so far in 2023, amid deals worth RON21.6 million, as per stock market data.